Literature DB >> 15062132

Identification of pubic arch interference in prostate brachytherapy: simplifying the transrectal ultrasound technique.

Alastair Henderson1, Robert W Laing, Stephen E M Langley.   

Abstract

PURPOSE: We report a simplified technique allowing identification of pubic arch interference (PAI) using transrectal ultrasound (TRUS). METHODS AND MATERIALS: Fifty consecutive brachytherapy patients implanted using a two-stage technique were studied. The pubic arch was outlined using a marker pen on the ultrasound monitor screen during the dose planning ultrasound. Where pubic arch interference (PAI) was identified attempted needle passage was used to confirm PAI (n = 3).
RESULTS: Mean time to perform PAI assessment was 90 s. Three of 50 patients had PAI, which was confirmed by attempted needle passage. No patients required modification to the implant plan during the implant procedure.
CONCLUSIONS: TRUS reliably identifies PAI. This simple technique may be used with any TRUS scanner and avoids the need for CT scanning or specific software to identify PAI. Our low incidence of PAI may be related to lower prostate volumes at implantation due to patient selection, neoadjuvant androgen deprivation, or improved patient positioning.

Entities:  

Mesh:

Year:  2003        PMID: 15062132     DOI: 10.1016/j.brachy.2003.11.001

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  5 in total

1.  Robotic needle guide for prostate brachytherapy: clinical testing of feasibility and performance.

Authors:  Danny Y Song; Everette C Burdette; Jonathan Fiene; Elwood Armour; Gernot Kronreif; Anton Deguet; Zhe Zhang; Iulian Iordachita; Gabor Fichtinger; Peter Kazanzides
Journal:  Brachytherapy       Date:  2010-08-21       Impact factor: 2.362

2.  Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging.

Authors:  Geoffrey V Martin; Thomas J Pugh; Usama Mahmood; Rajat J Kudchadker; Jihong Wang; Teresa L Bruno; Tharakeswara Bathala; Steven J Frank
Journal:  Brachytherapy       Date:  2017-03-09       Impact factor: 2.362

3.  Use of 5-alpha-reductase inhibitors as alternatives to luteinizing-hormone releasing hormone (LHRH) analogs or anti-androgens for prostate downsizing before brachytherapy.

Authors:  Hee Joon Bae; Omar Mian; Dhananjay Vaidya; Theodore L DeWeese; Daniel Y Song
Journal:  Pract Radiat Oncol       Date:  2017-10-10

Review 4.  Stromal Androgen Receptor in Prostate Cancer Development and Progression.

Authors:  Damien A Leach; Grant Buchanan
Journal:  Cancers (Basel)       Date:  2017-01-22       Impact factor: 6.639

5.  Predicting pubic arch interference in permanent prostate brachytherapy based on the specific parameters derived from nuclear magnetic resonance imaging.

Authors:  Yupeng Zheng; Jixiang Wu; Shan Chen; Yuexin Liu; Guangyin Zhang
Journal:  J Contemp Brachytherapy       Date:  2018-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.